Maus MV - Search Results

1

Biomanufacturing for clinically advanced cell therapies.

Aijaz A, Li M, Smith D, Khong D, LeBlon C, Fenton OS, Olabisi RM, Libutti S, Tischfield J, Maus MV, Deans R, Barcia RN, Anderson DG, Ritz J, Preti R, Parekkadan B. Aijaz A, et al. Among authors: maus mv. Nat Biomed Eng. 2018 Jun;2(6):362-376. doi: 10.1038/s41551-018-0246-6. Epub 2018 Jun 11. Nat Biomed Eng. 2018. PMID: 31011198 Free PMC article. Review.

2

CD19-Targeted CAR T Cells: A New Tool in the Fight against B Cell Malignancies.

Miller BC, Maus MV. Miller BC, et al. Among authors: maus mv. Oncol Res Treat. 2015;38(12):683-90. doi: 10.1159/000442170. Epub 2015 Nov 18. Oncol Res Treat. 2015. PMID: 26633875 Free article. Review.

3

Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cells.

Fraietta JA, Schwab RD, Maus MV. Fraietta JA, et al. Among authors: maus mv. Semin Oncol. 2016 Apr;43(2):291-9. doi: 10.1053/j.seminoncol.2016.02.006. Epub 2016 Feb 9. Semin Oncol. 2016. PMID: 27040708 Free PMC article. Review.

4

CAR-T Cell Therapies From the Transfusion Medicine Perspective.

Fesnak A, Lin C, Siegel DL, Maus MV. Fesnak A, et al. Among authors: maus mv. Transfus Med Rev. 2016 Jul;30(3):139-45. doi: 10.1016/j.tmrv.2016.03.001. Epub 2016 Mar 28. Transfus Med Rev. 2016. PMID: 27067907 Free PMC article. Review.

5

The Why, what, and How of the New FACT standards for immune effector cells.

Maus MV, Nikiforow S. Maus MV, et al. J Immunother Cancer. 2017 Apr 18;5:36. doi: 10.1186/s40425-017-0239-0. eCollection 2017. J Immunother Cancer. 2017. PMID: 28428885 Free PMC article.

6

Immunotherapy for Glioblastoma: Adoptive T-cell Strategies.

Choi BD, Maus MV, June CH, Sampson JH. Choi BD, et al. Among authors: maus mv. Clin Cancer Res. 2019 Apr 1;25(7):2042-2048. doi: 10.1158/1078-0432.CCR-18-1625. Epub 2018 Nov 16. Clin Cancer Res. 2019. PMID: 30446589 Free PMC article. Review.

7

Closed loop bioreactor system for the ex vivo expansion of human T cells.

Li M, Chin LY, Shukor S, Tamayo A, Maus MV, Parekkadan B. Li M, et al. Among authors: maus mv. Cytotherapy. 2019 Jan;21(1):76-82. doi: 10.1016/j.jcyt.2018.10.009. Epub 2018 Nov 27. Cytotherapy. 2019. PMID: 30497956 Free PMC article.

8

Wishing on a CAR: Understanding the Scope of Intrinsic T-cell Deficits in Patients with Cancer.

Leick M, Maus MV. Leick M, et al. Among authors: maus mv. Cancer Discov. 2019 Apr;9(4):466-468. doi: 10.1158/2159-8290.CD-19-0073. Cancer Discov. 2019. PMID: 30936218

9

Gene editing for immune cell therapies.

Bailey SR, Maus MV. Bailey SR, et al. Among authors: maus mv. Nat Biotechnol. 2019 Dec;37(12):1425-1434. doi: 10.1038/s41587-019-0137-8. Epub 2019 Jun 3. Nat Biotechnol. 2019. PMID: 31160723 Review.

10

Effects of intermittent T-cell cluster disaggregation on proliferative capacity and checkpoint marker expression.

Li M, Chin LY, Shukor S, Tamayo AG, Maus MV, Parekkadan B. Li M, et al. Among authors: maus mv. Autoimmunity. 2019 May;52(3):102-107. doi: 10.1080/08916934.2019.1630064. Epub 2019 Jun 25. Autoimmunity. 2019. PMID: 31238751 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

181 results

Search Page